Evaluation and Implementation Preparation of a Proactive Palliative Care Model (ENABLE-SG)
ENABLE-SG (Educate, Nurture, Advise, Before Life Ends for Singapore) as a Proactive Palliative Care Model: Evaluation and Implementation Preparation
National Cancer Centre, Singapore
715 participants
Dec 26, 2023
INTERVENTIONAL
Conditions
Summary
The current interdisciplinary specialist palliative care model focuses on supporting patients with advanced cancer who have complex problems in the last weeks of life. Consequently, palliative care is often provided late and in response to uncontrolled symptoms during crises. Palliative care models should shift from this reactionary illness-stress paradigm to a proactive health-wellness approach that is integrated early in the patient's disease trajectory. A proactive early palliative care telehealth model, ENABLE (Educate, Nurture, Advise, Before Life Ends), was developed in the U.S. to coach patients with advanced cancers and their family caregivers on how to cope effectively with serious illness. By empowering individuals early before acute distress and symptoms occur, patients and families can better mitigate and avoid crises. Building on positive health outcomes demonstrated by the ENABLE model in the U.S., the study team has successfully pilot-tested a culturally adapted ENABLE-SG model in Singapore. This study seeks to test the effectiveness of this ENABLE-SG model among patients with recently diagnosed advanced cancer and their caregivers while simultaneously collecting data on real-world implementation.
Eligibility
Inclusion Criteria12
- Adult aged 21 and above
- Within 60 days of being informed of an advanced cancer diagnosis, defined as metastatic or recurrent/ progressive Stage III/IV solid tumour
- Able to speak English or Chinese
- Able to provide informed consent
- Patients will NOT need to have a caregiver willing to participate in the ENABLE-SG programme.
- Adult aged 21 and above
- Self-endorsing or identified by the enrolled patient as an unpaid spouse/partner, relative or friend who knows them well and who provides regular support (at least 7 hours a week) due to their cancer and who does not have to live in the same dwelling
- Able to speak English or Chinese.
- Able to provide informed consent
- 21 years or older.
- Approached to participate in the ENABLE-SG study
- Able to provide informed consent
Exclusion Criteria7
- Medical record documentation of an active severe mental illness, dementia, active suicidal ideation, uncorrected hearing loss
- Unable to complete patient-reported outcome measures
- Has been reviewed by palliative care services in the current model of palliative care.
- Self-reported severe mental illness, dementia, active suicidal ideation, uncorrected hearing loss
- Unable to complete caregiver-reported outcomes.
- Healthcare professionals that are not providing care for cancer patients.
- Unable to complete interviews.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients and caregivers will receive individual structured psycho-educational sessions with a health coach. These sessions will be primarily delivered over the phone. Patient and caregiver dyads will have different health coaches. Patients will have six sessions on the topics of maintaining positivity, self-care, coping with stress, managing symptoms, exploring what matters most, and life review. Caregivers will have four sessions on the topics of maintaining positivity, self-care, coping with stress, and managing symptoms. All sessions will begin with screening for distress using the Distress Thermometer and Problem List culturally adapted from the National Comprehensive Cancer Network. From screening results, the health coach can flexibly change the order of the topics to address specific problems. It will take approximately three months to complete all sessions.
* 6-month wait-list control. Participants will receive the ENABLE-SG model six months after baseline (six sessions for patients and four sessions for caregivers) at an approximately weekly interval. * Interventions: ENABLE-SG model
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06044441